Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel

Published:2015-11-02 Issue:1 Volume:35 Page:593-601
ISSN:1021-335X
Container-title:Oncology Reports
language:en
Short-container-title:

Author:

SEINO MANABU,OKADA MASASHI,SAKAKI HIROTSUGU,TAKEDA HIROYUKI,WATARAI HIKARU,SUZUKI SHUHEI,SEINO SHIZUKA,KURAMOTO KENTA,OHTA TSUYOSHI,NAGASE SATORU,KURACHI HIROHISA,KITANAKA CHIFUMI

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRLF1 bridges AKT and mTORC2 through SIN1 to inhibit pyroptosis and enhance chemo-resistance in ovarian cancer;Cell Death & Disease;2024-09-10

2. Aggresome formation promotes ASK1/JNK signaling activation and stemness maintenance in ovarian cancer;Nature Communications;2024-02-13

3. Hypoxia-induced paclitaxel resistance in cervical cancer modulated by miR-100 targeting of USP15;Gynecologic Oncology Reports;2023-02

4. Circular RNA circ_0004488 Increases Cervical Cancer Paclitaxel Resistance via the miR-136/MEX3C Signaling Pathway;Journal of Oncology;2022-11-17

5. Inhibition of c-Jun N-terminal kinase signaling promotes osteoblastic differentiation of periodontal ligament stem cells and induces regeneration of periodontal tissues;Archives of Oral Biology;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP